63
Participants
Start Date
September 19, 2017
Primary Completion Date
December 15, 2020
Study Completion Date
February 15, 2022
Rapamycin
tablets containing Rapamycin/placebo will be administered based on body surface area and adjusted taking into consideration plasma rapamycin dosage
Placebo Oral Tablet
tablets containing Rapamycin/placebo will be administered based on body surface area and adjusted taking into consideration plasma rapamycin dosage
Centro Sla, Ospedale Civile S. Agostino Estense, A.O.U. Modena, Modena
Centro Sla, Irccs A.O.U. S.Martino Ist, Genova, Genova
Centro Clinico Nemo, Fondazione Serena Onlus, Milano, Milan
Centro Sla, Irccs Istituto Carlo Besta, Milano, Milan
Centro Sla, A.O.U. Maggiore Della Carita', Novara, Novara
Centro Sla, Universita' Di Padova, Padua
Centro Sla, Universita' Di Torino, Torino
University of Modena and Reggio Emilia
OTHER
Azienda Ospedaliero Universitaria Maggiore della Carita
OTHER
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
OTHER
University of Turin, Italy
OTHER
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER
Azienda Ospedaliera Niguarda Cà Granda
OTHER
Fondazione Salvatore Maugeri
OTHER
University of Padova
OTHER
Azienda Ospedaliero-Universitaria di Modena
OTHER